H. Schmid

726 total citations
35 papers, 448 citations indexed

About

H. Schmid is a scholar working on Oncology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, H. Schmid has authored 35 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Cancer Research and 7 papers in Reproductive Medicine. Recurrent topics in H. Schmid's work include Ovarian cancer diagnosis and treatment (7 papers), Breast Cancer Treatment Studies (5 papers) and Estrogen and related hormone effects (4 papers). H. Schmid is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Breast Cancer Treatment Studies (5 papers) and Estrogen and related hormone effects (4 papers). H. Schmid collaborates with scholars based in Germany. H. Schmid's co-authors include M. Kaufmann, G. Bastert, H. Junkermann, Hans‐Peter Sinn, Jens Huober, W. Scholz, H. Weigmann, W Kühn, G. Feichter and R. Kreienberg and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Haematology and Nuclear Physics A.

In The Last Decade

H. Schmid

34 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Schmid Germany	11	180	175	106	80	76	35	448
Rosie Cooke United Kingdom	12	165 0.9×	80 0.5×	35 0.3×	90 1.1×	132 1.7×	28	542
B. Duggan United States	12	218 1.2×	116 0.7×	181 1.7×	57 0.7×	173 2.3×	20	852
Theo H. M. Falke Netherlands	12	70 0.4×	74 0.4×	99 0.9×	46 0.6×	29 0.4×	18	485
Masataka Adachi Japan	15	110 0.6×	182 1.0×	169 1.6×	52 0.7×	147 1.9×	41	790
Ann Prys Davies United Kingdom	6	83 0.5×	84 0.5×	467 4.4×	128 1.6×	56 0.7×	9	634
Cristian Fernández Spain	9	298 1.7×	307 1.8×	52 0.5×	48 0.6×	103 1.4×	28	646
Masashi Moriyama Japan	8	125 0.7×	63 0.4×	38 0.4×	13 0.2×	130 1.7×	15	383
Michiel Simons Netherlands	12	190 1.1×	42 0.2×	162 1.5×	55 0.7×	55 0.7×	32	500
Claire L. Mitchell United Kingdom	8	107 0.6×	71 0.4×	53 0.5×	14 0.2×	51 0.7×	12	321
K. Tatebe United States	10	134 0.7×	166 0.9×	116 1.1×	28 0.3×	34 0.4×	28	752

Countries citing papers authored by H. Schmid

Since Specialization

Citations

This map shows the geographic impact of H. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Schmid more than expected).

Fields of papers citing papers by H. Schmid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Schmid. The network helps show where H. Schmid may publish in the future.

Co-authorship network of co-authors of H. Schmid

This figure shows the co-authorship network connecting the top 25 collaborators of H. Schmid. A scholar is included among the top collaborators of H. Schmid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Schmid. H. Schmid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schmid, H., Helmut Schiffl, & Stephan R. Lederer. (2012). Die akute Nierenschädigung. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 107(2). 141–146. 1 indexed citations

Schmid, H., Helmut Schiffl, & Stephan R. Lederer. (2011). Die akute Nierenschädigung. Intensivmedizin und Notfallmedizin. 48(6). 468–473. 3 indexed citations

Hohaus, Stefan, S Murea, Yung‐Sheng Lin, et al.. (1997). Immunomagnetic selection of CD34⁺peripheral blood stem cells for autografting in patients with breast cancer. British Journal of Haematology. 97(4). 881–888. 41 indexed citations

Haus, Ulrike, et al.. (1997). Treatment of prolonged chemotherapy induced severe thrombocytopenia with recombinant human interleukin-3???a report on four cases. Anti-Cancer Drugs. 8(3). 288–292. 2 indexed citations

Kaufmann, M., Gϋnter von Minckwitz, Walther Kuhn, et al.. (1995). Combination of new biologic parameters as a prognostic index in epithelial ovarian carcinoma. International Journal of Gynecological Cancer. 5(1). 49–55. 12 indexed citations

Sinn, Hans‐Peter, H. Schmid, H. Junkermann, et al.. (1994). Histologische Regression des Mammakarzinoms nach primärer (neoadjuvanter) Chemotherapie. Geburtshilfe und Frauenheilkunde. 54(10). 552–558. 120 indexed citations

Kaufmann, M., et al.. (1994). Combination of Grading and New Biological Factors (S-Phase Fraction and Epidermal Growth Factor Receptor) Can Predict Relapse and Survival in Patients with Node-Negative Primary Breast Cancer. Oncology Research and Treatment. 17(2). 166–172. 3 indexed citations

Minckwitz, G von, W Kühn, M. Kaufmann, et al.. (1994). Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer. International Journal of Gynecological Cancer. 4(4). 250–256. 7 indexed citations

Minckwitz, Gϋnter von, et al.. (1991). Hormonelle Folgetherapien nach Goserelin (Zoladex®) beim metastasierten Mammakarzinom prämenopausaler Patientinnen. Archives of Gynecology and Obstetrics. 250(1-4). 258–264. 1 indexed citations

10.

Kaufmann, Max, H. Schmid, U. Raeth, et al.. (1990). Aszites-Therapie mit Tumornekrosefaktor beim Ovarialkarzinom. Geburtshilfe und Frauenheilkunde. 50(9). 678–682. 12 indexed citations

11.

Worst, P., et al.. (1990). Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer. Cancer Chemotherapy and Pharmacology. 26(S1). S87–S90. 14 indexed citations

12.

Kühn, W, et al.. (1989). DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors. Gynecologic Oncology. 33(3). 360–367. 44 indexed citations

13.

Schmid, H., et al.. (1989). ZOLADEX als Depot GnRH-Agonist beim prämenopausalen metastasierten Mammakarzinom. Archives of Gynecology and Obstetrics. 245(1-4). 741–743. 2 indexed citations

14.

Kaufmann, M, W. Jonat, Ulrich R. Kleeberg, et al.. (1989). Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.. Journal of Clinical Oncology. 7(8). 1113–1119. 77 indexed citations

15.

Kaufmann, M., H. Schmid, Ludwig Kiesel, & K. Klinga. (1988). GnRH-Agonisten (Zoladex)-Therapie bei prämenopausalen Frauen mit metastasierendem Mammakarzinom*. Geburtshilfe und Frauenheilkunde. 48(7). 528–532. 5 indexed citations

16.

Schmid, H., et al.. (1988). CA 15-3 und CEA als Tumormarker zur Rezidivdiagnostik beim Mammakarzinom. Geburtshilfe und Frauenheilkunde. 48(5). 309–312. 5 indexed citations

17.

Fritze, Dieter, W. Queißer, H. Schmid, et al.. (1986). Prospective Randomized Trial Concerning Hyper- and Normoprolactinemia and the Use of Bromoergocryptine in Patients with Metastatic Breast Cancer. Oncology Research and Treatment. 9(6). 305–312. 10 indexed citations

18.

Schmid, H., et al.. (1974). Herkunft des Nachleuchtens in einer gepulsten Argonentladung. 268(2). 129–132. 3 indexed citations

19.

Schmid, H.. (1969). Das Spektrum der Entladungsphotonen im Argon-Alkohol-Zählrohr. Zeitschrift für Physik A Hadrons and Nuclei. 221(2). 175–185. 1 indexed citations

20.

Schmid, H., et al.. (1953). Beobachtungen und Gedanken zum Rückgang der Tanne. Forstwissenschaftliches Centralblatt. 72(3-4). 101–110. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact